Article

2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 74, n° 2
pages 374-375 (février 2016)
Doi : 10.1016/j.jaad.2015.08.055
Research Letters

HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up
 

Marina Talamonti, MD a, , Marco Galluzzo, MD a, Sergio Chimenti, MD a, Antonio Costanzo, MD b
a Department of Dermatology, University of Rome “Tor Vergata”, Rome, Italy 
b Dermatology Unit, Neurosciences, Mental Health, and Sensory Organs Department, Sapienza University of Rome, Rome, Italy 

Correspondence to: Marina Talamonti, MD, Department of Dermatology, University of Rome “Tor Vergata,” Viale Oxford 81, 00133 Rome, Italy.

 The first two authors contributed equally to this work.
 Funding sources: None.
 Disclosure: Dr Chimenti served as a speaker for Pfizer, Abbvie, and MSD. Dr Costanzo served as a speaker for Pfizer and Abbvie. Drs Talamonti and Galluzzo have no conflicts of interest to declare.


Top of the page

© 2015  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@